Tuesday, June 18, 2013 Last update: 2:46 PM
Company Tech News as it Breaks
Trade Events
NPS Pharmaceuticals, Inc.
News articles for NPS Pharmaceuticals, Inc.:
Monday, June 17, 2013
- Findings Presented at ENDO 2013 Support Therapeutic Potential of Natpara® as Parathyroid Hormone Replacement Therapy in Patients with HypoparathyroidismNPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, yesterday presented findings supporting ... read moreInitial Findings from PARADOX, Largest and Most Comprehensive Research Analyzing the Burden of Hypoparathyroidism, Reveals Collection of Nearly 40 Physical, Cognitive, Emotional SymptomsNPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, yesterday presented initial findings from ... read more
Friday, June 14, 2013
- NPS Pharmaceuticals’ President and CEO Dr. Francois Nader Receives Ernst & Young Entrepreneur Of The Year® 2013 Award in New JerseyNPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced that president and chief ... read more
Wednesday, June 5, 2013
- NPS Pharmaceuticals to Present Data from Natpara™ REPLACE Study and PARADOX Study at ENDO 2013, The Endocrine Society’s 95th Annual MeetingNPS Pharmaceuticals, Inc., a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today reported that two abstracts related to the ... read more
Friday, May 31, 2013
- NPS Pharmaceuticals Joins the Hypoparathyroidism Association in Recognition of World Hypoparathyroidism Awareness DayNPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced its support for World ... read more
Wednesday, May 29, 2013
- NPS Pharmaceuticals to Present at Jefferies Global Healthcare ConferenceNPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the Jefferies 2013 Global Healthcare Conference in New York on Monday, June 3, 2013 at 10:00 a.m. ET. The presentation ... read more
Tuesday, May 28, 2013
- NPS Pharmaceuticals Announces Exercise of Over-Allotment Option and Closing of Public OfferingNPS Pharmaceuticals, Inc. (NASDAQ: NPSP) today reported that it has closed its recently announced public offering of common stock. The total number of shares sold was 6,900,000, comprised of ... read more
Wednesday, May 22, 2013
- NPS Pharmaceuticals to Present at Deutsche Bank Health Care ConferenceNPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the Deutsche Bank Securities 38th Annual Health Care Conference in Boston on Wednesday, May 29, 2013 at 8:00 a.m. ET. ... read more
Tuesday, May 21, 2013
- NPS Pharmaceuticals Prices Public Offering of Common StockNPS Pharmaceuticals, Inc. (NASDAQ: NPSP) today announced the pricing of an underwritten public offering of 6,000,000 shares of its common stock at a price of $14.53 per share to ... read more
Monday, May 20, 2013
- NPS Pharmaceuticals Announces Proposed Public Offering of 6,000,000 Shares of its Common StockNPS Pharmaceuticals, Inc. (NASDAQ: NPSP), today announced that it has commenced an underwritten public offering of 6,000,000 shares of its common stock. All of the shares in the ... read more
Thursday, May 16, 2013
- NPS Pharmaceuticals President and CEO Dr. Francois Nader Recognized as Regional Finalist for Ernst & Young Entrepreneur of the Year® 2013NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced that president and chief ... read more
Thursday, May 9, 2013
- NPS Pharmaceuticals Reports First Quarter 2013 Financial ResultsNPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, reported its results for the first ... read more
Wednesday, May 1, 2013
- NPS Pharmaceuticals to Report First Quarter 2013 Financial ResultsNPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today that it will report its first quarter 2013 financial results on Thursday, May 9, 2013 at approximately 8:00 a.m. ET. The ... read more
Monday, March 18, 2013
- NPS Pharmaceuticals and Takeda Revise Agreements and NPS Re-Gains Full Worldwide Rights to Teduglutide and Recombinant Human Parathyroid Hormone 1-84NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) and Takeda Pharmaceutical Company Limited (TSE: 4502, “Takeda”) announced today that NPS has re-gained the full worldwide rights to teduglutide (trade name in ... read more
Tuesday, March 5, 2013
- NPS Pharmaceuticals to Present at Barclays Capital Global Healthcare ConferenceNPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the Barclays Capital Global Healthcare Conference in Miami, Florida on Wednesday, March 13, 2013 at 11:15 a.m. ET. The presentation ... read more
Thursday, February 28, 2013
- NPS Pharmaceuticals Observes Rare Disease Day 2013 and Celebrates 30th Anniversary of National Organization for Rare DisordersNPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, is joining the National Organization for ... read more
Thursday, February 21, 2013
- NPS Pharmaceuticals Reports 2012 Financial Results and 2013 GuidanceNPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, reported its results for the fourth ... read more
Wednesday, February 13, 2013
- NPS Pharmaceuticals to Report 2012 Financial ResultsNPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today that it will report its 2012 financial results on Thursday, February 21, 2013 at approximately 4:00 p.m. ET. The press release ... read more
Tuesday, February 5, 2013
- NPS Pharmaceuticals to Present at Upcoming ConferencesNPS Pharmaceuticals, Inc. (NASDAQ: NPSP) is scheduled to present at the 15th Annual Bio CEO & Investor Conference in New York on Monday, February 11, 2013 at 10:30 ... read more
Thursday, January 3, 2013
- NPS Pharmaceuticals to Present at J.P. Morgan Healthcare ConferenceNPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco Wednesday, January 9, 2013 at 9:00 a.m. PT. The presentation ... read more